2018. Comparison Study of the Effect of Erlotinib as a Tyrosine Kinase Inhibitor on Electrolyte Levels in Type2 Diabetic and Diabetic Nephropathy. Ibn AL-Haitham Journal For Pure and Applied Sciences. 31, 3 (Nov. 2018), 63–69. DOI:https://doi.org/10.30526/31.3.2011.